| Description |
CD83 molecule |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
| Image |
|
|
| GO Annotations |
Cellular Component |
|
|
| Molecular Function |
|
|
| Biological Process |
|
|
| Pathways |
|
|
| Drugs |
|
|
| Diseases |
|
|
| GWAS |
- Breast cancer and/or colorectal cancer ( 29698419)
- California verbal learning test score ( 31596458)
- Chronotype ( 30696823)
- Obesity-related traits ( 23251661)
- Response to tofacitinib treatment (herpes zoster) ( 33455090)
- Response to tofacitinib treatment (herpes zoster)(time to event) ( 33455090)
- Response to tofacitinib treatment in psoriasis (herpes zoster) ( 33455090)
- Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event) ( 33455090)
- Rheumatoid arthritis ( 30423114 22446963 24390342)
|
- Gut microbiota (bacterial taxa, hurdle binary method) ( 32572223)
- Heel bone mineral density ( 30598549)
- Leisure-time exercise behaviour ( 19727025)
- Magnesium levels ( 26685716)
- Serum metabolite levels ( 33031748)
|
| Interacting Genes |
10 interacting genes:
EIF4E
FAM8A1
FATE1
GCM2
GMPR
KIF13A
NOL7
PAPSS2
SACS
SPP1
|
6 interacting genes:
APP
CD83
CEP19
DAPK1
HSF2BP
TLL2
|
| Entrez ID |
9308 |
9060 |
| HPRD ID |
05170 |
04303 |
| Ensembl ID |
ENSG00000112149
|
ENSG00000198682
|
| Uniprot IDs |
A0A087WX61
Q01151
|
O95340
Q5TB52
|
| PDB IDs |
5MIX
5MJ0
5MJ1
5MJ2
|
2AX4
|
| Enriched GO Terms of Interacting Partners? |
|
|
| Tagcloud ? |
|
|
| Tagcloud (Difference) ? |
|
|
| Tagcloud (Intersection) ? |
|